Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | NQO2 | P16083 | 3/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.48 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13156551 | 1.00 | MAPT (0.71) | MAPTALDH1A1HPGDKDM4EGAA | |
| SCHEMBL13500415 | 0.85 | MAPT (0.53) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL27643128 | 0.84 | MAPT (1.00) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL29356959 | 0.84 | MAPT (1.00) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL9049 | 0.84 | MAPT (1.00) | MAPTALDH1A1HPGDKDM4EGAA | |
| SCHEMBL2422494 | 0.81 | MAPT (0.56) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL20475337 | 0.80 | MAPT (0.92) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL22345160 | 0.80 | MAPT (0.92) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL20475326 | 0.80 | MAPT (0.92) | MAPTALDH1A1HPGDKDM4EGAA | |
| Phenazine SCHEMBL10866237 | 0.80 | MAPT (0.92) | MAPTALDH1A1HPGDKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540228-B2 | Cross linked surface coating and interfacial layer for a perovskite material photovoltaic device | CUBICPV INC. (US) | 2026-02-03 | — | — | US | disclosed |
| EP-4660349-A2 | PEROVSKITE MATERIAL LAYER PROCESSING | CubicPV Inc. (GB) | 2025-12-10 | — | — | EP | disclosed |
| CN-119404620-A | Ionic liquid perovskite device | 立方光伏股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-119136633-A | Enhanced perovskite materials for photovoltaic devices | 立方光伏股份有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240407247-A1 | Multi-Junction Perovskite Material Devices | CUBICPV INC. | 2024-12-05 | — | — | US | disclosed |
| CN-113272311-B | Enhanced perovskite materials for photovoltaic devices | 亨特钙钛矿技术有限责任公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118592107-A | Method for forming perovskite material layer | 立方光伏股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118556111-A | Lead chelating materials for perovskite devices | 立方光伏股份有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-118486550-A | Mixed perovskite material processing | 立方光伏股份有限公司 | 2024-08-13 | — | — | CN | disclosed |
| US-20240114766-A1 | Cross Linked Surface Coating and Interfacial Layer for a Perovskite Material Photovoltaic Device | CUBIC PEROVSKITE LLC | 2024-04-04 | — | — | US | disclosed |
| US-20230357632-A1 | IONIC LIQUID PEROVSKITE DEVICES | CUBICPV INC. | 2023-11-09 | — | — | US | disclosed |
| CN-115911370-A | Novel negative electrode material for water-based battery, water-based battery and preparation method of water-based battery | 广西电网有限责任公司电力科学研究院 | 2023-04-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540228-B2 | Cross linked surface coating and interfacial layer for a perovskite material photovoltaic device | HCN2, HCN1, BRSK1 | MAPT 1812/4885ALDH1A1 2071/4885HPGD 3163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.